Mass General Cancer Center — Boston, Massachusetts

Mass General Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Clinical Trials Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Mass General Cancer Center has participated in 9 clinical trials with 6 currently active.

Therapeutic areas: Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer, NSCLC.

Sponsors: Incendia Therapeutics, Bayer, Sutro Biopharma, Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General Cancer Center?

Mass General Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General Cancer Center conducted?

Mass General Cancer Center has 9 clinical trials on record, with 6 currently active. Their work covers Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer, NSCLC.

Is Mass General Cancer Center accredited by Crixeo Clinical Trials?

Mass General Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.